Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Relative Effectiveness of Schizophrenia Therapy Study
This clinical trial studying the relative effectiveness of schizophrenia therapy has completed. The study also includes bipolar disorder amo…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
This update reports results from a youth-focused trial evaluating the effectiveness and tolerability of a second-generation antipsychotic ac…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: First Episode Schizophrenia and Cannabis-Related Disorder Study [NA]
Clinical trial update for a study on first-episode schizophrenia with cannabis-related and substance-related disorders; the study has comple…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients [Phase 2]
A Phase 2 trial comparing talnetant, risperidone, and placebo in schizophrenic patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients [NA]
A completed clinical trial evaluating self-regulation strategies to improve exercise behavior in people with schizophrenia or schizoaffectiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint [Phase 3]
A Phase 3 clinical trial comparing bifeprunox to risperidone in outpatient schizophrenia, using weight change as the primary endpoint; the s…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Study Evaluating Bifeprunox in Patients With Schizophrenia. [Phase 3]
A Phase 3 study evaluating Bifeprunox in schizophrenia has been terminated. The sponsor Wyeth, now part of Pfizer, terminated the trial.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia [Phase 4]
A Phase 4 clinical trial led by the National Institute of Mental Health compared optimal antipsychotic treatments in adults with schizophren…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics
A completed observational study comparing outcomes for schizophrenia patients treated with paliperidone ER versus other oral antipsychotics.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Effect of Single Dose Intranasal Insulin On Cognitive Function [Phase 4]
Update on a Phase 4 trial evaluating whether a single dose of intranasal insulin improves cognitive function in schizophrenia and schizoaffe…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: A Placebo-Controlled, Cross-Over Trial of Aripiprazole [Phase 4]
Phase 4, placebo-controlled, cross-over trial evaluating aripiprazole in schizophrenia. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating ziprasidone for diabetes mellitus associated with clozapine or olanzapine use in schizophrenia; results po…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Transcranial Magnetic Stimulation for "Voices" [Phase 2]
Phase 2 trial updates on transcranial magnetic stimulation for auditory hallucinations in schizophrenia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oculomotor and Spatial Cognition Deficits in Schizophrenia [NA]
A terminated clinical study on oculomotor and spatial cognition deficits in schizophrenia has posted results (NCT00931996).
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of ascending, multiple oral doses of SPD489 in adults with schizophrenia has completed w…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Long-Term Study in Schizophrenia [Phase 3]
A long-term Phase 3 study in schizophrenia sponsored by Eli Lilly has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Long-Term, Open-Label, Study on Schizophrenia [Phase 2, Phase 3]
This update notes the termination of a long-term, open-label schizophrenia trial conducted in Phase 2/Phase 3 by Eli Lilly and Company; no r…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: L-carnosine for Schizophrenia [NA]
The clinical trial database entry reports completion of a study evaluating L-carnosine for schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Effects of Motivating People With Schizophrenia to Exercise [NA]
This document reports a completed clinical trial investigating strategies to motivate individuals with schizophrenia to engage in exercise.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of SEROQUEL XR (quetiapine extended-release) in adults with acute schizophrenia; res…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Naltrexone Treatment of Alcohol Abuse in Schizophrenia [Phase 4]
A Phase 4 clinical trial assessing naltrexone for alcohol use disorder in individuals with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia [Phase 3]
A Phase 3 trial (SR-Registration Study 1) evaluating the efficacy and safety of quetiapine (Seroquel) in patients with schizophrenia has com…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia [Phase 3]
A Phase 3 trial comparing quetiapine fumarate (SEROQUEL) to placebo in adolescents with schizophrenia has completed, per the update.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo [Phase 3]
A Phase 3 trial sponsored by AstraZeneca evaluated relapse prevention in stable chronic schizophrenia patients, comparing Seroquel (quetiapi…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Seroquel on Glucose Metabolism [Phase 4]
Phase 4 trial update on quetiapine (Seroquel) and its effects on glucose metabolism in schizophrenia; completed study.